PVAM
IMMU

Pacific View Asset Management’s Immunomedics Inc IMMU Stock Holding History

Pacific View Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-33,850
Closed -$467K – 46
2019
Q2 		$467K Sell
33,850
-30,909
-48% -$465K 0.51% 42
2019
Q1 		$1.25M Sell
64,759
-144,409
-69% -$2.33M 1.29% 23
2018
Q4 		$2.99M Buy
209,168
+56,050
+37% +$1.11M 3.51% 12
2018
Q3 		$3.19M Buy
153,118
+103,951
+211% +$2.46M 2.54% 15
2018
Q2 		$1.16M Buy
49,167
+30,990
+170% +$623K 0.92% 25
2018
Q1 		$265K Buy
+18,177
New +$297K 0.2% 97

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Pacific View Asset Management's IMMU Position: Q3 2019 in Review

Pacific View Asset Management sold out of Immunomedics Inc (IMMU) in Q3 2019, closing a stake of 33,850 shares — an estimated $467K sold.

Pacific View Asset Management first reported a position in IMMU in Q1 2018 and held it in 6 quarters. The position peaked at $3.19M in Q3 2018. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

  • Pacific View Asset Management reported no remaining Immunomedics Inc position as of Q3 2019 after selling out during the quarter.
  • Pacific View Asset Management sold 33,850 Immunomedics Inc shares in Q3 2019, an estimated $467K.
  • Pacific View Asset Management first reported a position in Immunomedics Inc in Q1 2018 and held it in 6 quarters.
  • Pacific View Asset Management's Immunomedics Inc position peaked at $3.19M in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.